#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study of belantamab mafodotin with bortezomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant

    Not recruiting

    1 1 1
    Investigated drugs:
    Spain

  • Study on the Effects of Glycerol Phenylbutyrate in Patients with Corticobasal Syndrome

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study of dose reduction strategy for tyrosine kinase inhibitors (imatinib, ponatinib, bosutinib, nilotinib, dasatinib) in patients with chronic myeloid leukemia

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Safety and Tolerability of Guanabenz in Children with Vanishing White Matter Disease

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study of Berubicin versus Lomustine in adult patients with recurrent Glioblastoma Multiforme after first-line treatment failure

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Spain

  • Study Comparing Cemiplimab to Platinum-Based Chemotherapy for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Greece Poland

  • Study on Isatuximab and CellProtect for Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant

    Not recruiting

    1 1 1
    Investigated drugs:
    Sweden

  • Study on Early Treatment for Multiple Myeloma Relapse Using Carfilzomib, Bortezomib, Daratumumab, Lenalidomide, and Dexamethasone in Patients with MRD Negativity

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Lithuania Norway

  • Study on the Effectiveness and Safety of Olaparib Alone and with Durvalumab for Patients with Early Stage HER2-Negative Breast Cancer with BRCA Mutations

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Germany Italy Spain

  • Study on the Effects of TransCon CNP in Children Aged 2-11 with Achondroplasia

    Not recruiting

    1
    Investigated drugs:
    Denmark Ireland Spain